Publicaciones en colaboración con investigadores/as de University of Pittsburgh (20)

2021

  1. Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function

    Translational Psychiatry, Vol. 11, Núm. 1

  2. Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study

    Journal of Infection, Vol. 83, Núm. 3, pp. 306-313

  3. Correction: Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function (Translational Psychiatry, (2021), 11, 1, (579), 10.1038/s41398-021-01705-z)

    Translational Psychiatry

  4. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit

    Schizophrenia Research, Vol. 227, pp. 10-17

  5. Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosis

    Human Brain Mapping, Vol. 42, Núm. 2, pp. 439-451

  6. Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes

    Neuropsychopharmacology, Vol. 46, Núm. 8, pp. 1468-1474

  7. Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19

    New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802

2020

  1. Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study

    Neuropsychopharmacology, Vol. 45, Núm. 4, pp. 641-648

  2. Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association with Clinical Outcome

    Schizophrenia Bulletin, Vol. 46, Núm. 3, pp. 670-679

2019

  1. ADGRL3 (LPHN3) variants predict substance use disorder

    Translational Psychiatry, Vol. 9, Núm. 1

2018

  1. Correction to: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis (Neuropsychopharmacology, (2018), 43, 13, (2652-2659), 10.1038/s41386-017-0004-6)

    Neuropsychopharmacology

  2. Cortical GABA in subjects at ultra-high risk of psychosis: Relationship to negative prodromal symptoms

    International Journal of Neuropsychopharmacology, Vol. 21, Núm. 2, pp. 114-119

  3. Increased resting hippocampal and basal ganglia perfusion in people at ultra high risk for psychosis: Replication in a second cohort

    Schizophrenia Bulletin, Vol. 44, Núm. 6, pp. 1323-1331

  4. Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis

    Neuropsychopharmacology, Vol. 43, Núm. 13, pp. 2652-2659

2015

  1. A global reference for human genetic variation

    Nature, Vol. 526, Núm. 7571, pp. 68-74

2014

  1. Inaccuracy of haemoglobin A1c among HIV-infected men: Effects of CD4 cell count, antiretroviral therapies and haematological parameters

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 12, pp. 3360-3367

2013

  1. Einteilung des Schweregrads der akuten Pankreatitis: Internationale, multidisziplinäre klinische Klassifikation auf Basis pathogenetischer Determinanten: Deutsche Version 2013

    Zeitschrift fur Gastroenterologie, Vol. 51, Núm. 6, pp. 544-550

2012

  1. Determinant-based classification of acute pancreatitis severity: An international multidisciplinary consultation

    Annals of Surgery, Vol. 256, Núm. 6, pp. 875-880

2010

  1. Comparison of interlaboratory variation in absolute T-cell counts by single-platform and optimized dual-platform methods

    Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. 3, pp. 194-200

2007

  1. Assessing immunophenotyping performance: Proficiency-validation for adopting improved flow cytometry methods

    Cytometry Part B - Clinical Cytometry, Vol. 72, Núm. 4, pp. 249-255